Lluch A - Search Results

1

Nitration of cathepsin D enhances its proteolytic activity during mammary gland remodelling after lactation.

Zaragozá R, Torres L, García C, Eroles P, Corrales F, Bosch A, Lluch A, García-Trevijano ER, Viña JR. Zaragozá R, et al. Among authors: lluch a. Biochem J. 2009 Apr 15;419(2):279-88. doi: 10.1042/BJ20081746. Biochem J. 2009. PMID: 19125694

2

Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients.

Chirivella I, Bermejo B, Insa A, Pérez-Fidalgo A, Magro A, Rosello S, García-Garre E, Martín P, Bosch A, Lluch A. Chirivella I, et al. Among authors: lluch a. Breast Cancer Res Treat. 2009 Apr;114(3):479-84. doi: 10.1007/s10549-008-0018-1. Epub 2008 May 8. Breast Cancer Res Treat. 2009. PMID: 18463977

3

Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research.

Bosch A, Eroles P, Zaragoza R, Viña JR, Lluch A. Bosch A, et al. Among authors: lluch a. Cancer Treat Rev. 2010 May;36(3):206-15. doi: 10.1016/j.ctrv.2009.12.002. Epub 2010 Jan 8. Cancer Treat Rev. 2010. PMID: 20060649 Review.

4

Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?

Pérez-Fidalgo JA, Pimentel P, Caballero A, Bermejo B, Barrera JA, Burgues O, Martinez-Ruiz F, Chirivella I, Bosch A, Martínez-Agulló A, Lluch A. Pérez-Fidalgo JA, et al. Among authors: lluch a. Breast. 2011 Dec;20(6):548-54. doi: 10.1016/j.breast.2011.06.005. Epub 2011 Aug 3. Breast. 2011. PMID: 21816613 Free article.

5

Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.

Eroles P, Bosch A, Pérez-Fidalgo JA, Lluch A. Eroles P, et al. Among authors: lluch a. Cancer Treat Rev. 2012 Oct;38(6):698-707. doi: 10.1016/j.ctrv.2011.11.005. Epub 2011 Dec 16. Cancer Treat Rev. 2012. PMID: 22178455 Review.

6

The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population.

Rodrigues P, Furriol J, Tormo E, Ballester S, Lluch A, Eroles P. Rodrigues P, et al. Among authors: lluch a. Breast Cancer Res Treat. 2012 Jun;133(2):769-78. doi: 10.1007/s10549-012-1980-1. Breast Cancer Res Treat. 2012. PMID: 22315135

7

Evolution of tumour biology upon progression. Do we know our enemy?

Lluch A, Bosch A. Lluch A, et al. Clin Transl Oncol. 2012 Jun;14(6):399-400. doi: 10.1007/s12094-012-0816-0. Clin Transl Oncol. 2012. PMID: 22634527 No abstract available.

8

Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects.

Pineda B, García-Pérez MÁ, Cano A, Lluch A, Eroles P. Pineda B, et al. Among authors: lluch a. PLoS One. 2013;8(1):e53902. doi: 10.1371/journal.pone.0053902. Epub 2013 Jan 16. PLoS One. 2013. PMID: 23342035 Free PMC article.

9

Identification of candidate polymorphisms on stress oxidative and DNA damage repair genes related with clinical outcome in breast cancer patients.

Rodrigues P, Furriol J, Bermejo B, Chaves FJ, Lluch A, Eroles P. Rodrigues P, et al. Among authors: lluch a. Int J Mol Sci. 2012 Dec 5;13(12):16500-13. doi: 10.3390/ijms131216500. Int J Mol Sci. 2012. PMID: 23443115 Free PMC article. Clinical Trial.

10

Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival.

Rodrigues P, Furriol J, Tormo E, Ballester S, Lluch A, Eroles P. Rodrigues P, et al. Among authors: lluch a. Mol Cell Biochem. 2013 Jul;379(1-2):181-90. doi: 10.1007/s11010-013-1640-8. Epub 2013 Apr 6. Mol Cell Biochem. 2013. PMID: 23716179

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

430 results

Search Page

Filters